Pluristem Therapeutics, Inc.
(NASDAQ : PSTI)

( )
PSTI After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. 0.80%63.941.0%$438.87m
AMGNAmgen, Inc. -0.72%235.041.3%$415.03m
BIIBBiogen, Inc. -1.35%284.211.4%$361.86m
ILMNIllumina, Inc. -1.21%327.003.5%$319.37m
VRTXVertex Pharmaceuticals, Inc. -0.30%233.911.9%$274.07m
REGNRegeneron Pharmaceuticals, Inc. -0.71%356.602.6%$229.47m
EXASEXACT Sciences Corp. -2.93%92.1824.0%$223.58m
ALXNAlexion Pharmaceuticals, Inc. -2.56%108.552.0%$165.88m
INCYIncyte Corp. -0.31%78.242.5%$128.46m
AAgilent Technologies, Inc. -1.23%89.021.6%$123.04m
SRPTSarepta Therapeutics, Inc. -3.93%113.6814.6%$106.56m
BMRNBioMarin Pharmaceutical, Inc. -2.24%85.634.3%$104.31m
SGENSeattle Genetics, Inc. 3.27%115.356.1%$95.31m
BLUEbluebird bio, Inc. -4.35%89.7214.2%$89.28m
ITCIIntra-Cellular Therapies, Inc. -2.59%24.869.0%$84.71m

Company Profile

Pluristem Therapeutics, Inc. engages in cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. It focuses on the development, clinical trials and manufacturing of cell therapeutics and related technologies. Its products include Clinical Pipeline, PLX-Immune, PLX-PAD, and PLX-R18. The company was founded by Doron Shorrer on May 11, 2001 and is headquartered in Haifa, Israel.